Letter excerpt:
Dear Members of the Utah Congressional Delegation,
On behalf of the undersigned organizations and the many constituents we represent, we would like to express our concern with the reintroduction of H.R. 3, The Lower Drug Costs Now Act, and urge you to oppose this legislation. H.R. 3 would have a devastating impact on patient access to critical medicines and would discourage the growth of and even penalize biopharmaceutical companies that are developing life-changing treatments and cures for patients.
Full letter below.
Utah-Congressional-Delegation-Ltr.-HR3-5.25.21